Clinical trials
Completed Phase 1 Lecithin Cholesterol Acyltransferase Deficiency trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 4 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2011 | 4 |
| 2012 | 11 |
| 2013 | 2 |
| 2014 | 3 |
| 2017 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 48 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| IPCA Laboratories Ltd. | 12 |
| Par Pharmaceutical, Inc. | 11 |
| Dr. Reddy's Laboratories Limited | 7 |
| Pfizer | 3 |
| AstraZeneca | 2 |
| Geropharm | 2 |
| Actavis Inc. | 1 |
| Bristol-Myers Squibb | 1 |
| Center for Clinical Pharmacology Research Bdbeq S.A. | 1 |
| Eisai Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lecithin Cholesterol Acyltransferase Deficiency | 48 |
| Atherosclerosis | 1 |
| Coronary Artery Disease | 1 |
| Insulin Resistance | 1 |
Trials
Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.